Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CYAD

Celyad

$21.35

(0.00%)

, ADAP

Adaptimmune

$3.83

-0.06 (-1.54%)

08:06
03/20/19
03/20
08:06
03/20/19
08:06
Conference/Events
William Blair to hold a conference »

9th Annual Cancer…

CYAD

Celyad

$21.35

(0.00%)

ADAP

Adaptimmune

$3.83

-0.06 (-1.54%)

ADRO

Aduro Biotech

$3.92

-0.1 (-2.49%)

ALLO

Allogene Therapeutics

$26.25

-0.53 (-1.98%)

ATRA

Atara Biotherapeutics

$39.18

0.02 (0.05%)

AUTL

Autolus Therapeutics

$25.05

0.05 (0.20%)

BLCM

Bellicum Pharmaceuticals

$3.62

0.06 (1.69%)

CALA

Calithera Biosciences

$6.50

-0.08 (-1.22%)

DVAX

Dynavax

$8.00

0.24 (3.09%)

FATE

Fate Therapeutics

$18.00

-0.35 (-1.91%)

HARP

Harpoon Therapeutics

$12.10

0.1 (0.83%)

INFI

Infinity Pharmaceuticals

$1.80

(0.00%)

MRK

Merck

$81.93

0.59 (0.73%)

MRUS

Merus

$12.85

-0.15 (-1.15%)

NKTR

Nektar

$34.40

-0.5 (-1.43%)

PFE

Pfizer

$42.32

0.51 (1.22%)

PIRS

Pieris Pharmaceuticals

$3.22

-0.11 (-3.30%)

RCUS

Arcus Biosciences

$11.64

-0.12 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 04

    Apr

  • 08

    Apr

  • 09

    Apr

  • 09

    Apr

  • 11

    Apr

  • 30

    Apr

  • 30

    Apr

  • 18

    May

  • 23

    May

  • 24

    May

  • 17

    Jun

Over a week ago
XBI

SPDR S&P BIOTECH

$90.52

1.46 (1.64%)

, AIMT

Aimmune

$23.29

0.26 (1.13%)

13:48
03/12/19
03/12
13:48
03/12/19
13:48
Recommendations
SPDR S&P BIOTECH, Aimmune, BioCryst, Deciphera, Fate Therapeutics, Global Blood Therapeutics, Immunomedics, Incyte, Jazz Pharmaceuticals, Sarepta analyst commentary at Piper Jaffray »

Biopharma stocks should…

XBI

SPDR S&P BIOTECH

$90.52

1.46 (1.64%)

AIMT

Aimmune

$23.29

0.26 (1.13%)

BCRX

BioCryst

$8.41

0.1 (1.20%)

DCPH

Deciphera

$27.08

0.29 (1.08%)

FATE

Fate Therapeutics

$17.03

0.48 (2.90%)

GBT

Global Blood Therapeutics

$52.22

0.95 (1.85%)

IMMU

Immunomedics

$17.45

-0.02 (-0.11%)

INCY

Incyte

$85.20

1.02 (1.21%)

JAZZ

Jazz Pharmaceuticals

$133.53

0.54 (0.41%)

SRPT

Sarepta

$135.32

0.97 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 12

    Mar

  • 18

    Mar

  • 20

    Mar

  • 20

    Mar

  • 24

    May

  • 19

    Aug

BTI

British American Tobacco

$39.71

1.25 (3.25%)

, IMBBY

Imperial Brands

$0.00

(0.00%)

10:29
03/06/19
03/06
10:29
03/06/19
10:29
On The Fly
FDA chief departure seen as positive for tobacco, uncertain for biopharma »

Commenting on the…

BTI

British American Tobacco

$39.71

1.25 (3.25%)

IMBBY

Imperial Brands

$0.00

(0.00%)

MO

Altria Group

$53.10

0.215 (0.41%)

PM

Philip Morris

$86.74

-0.26 (-0.30%)

AIMT

Aimmune

$24.76

-0.75 (-2.94%)

BCRX

BioCryst

$8.29

-0.04 (-0.48%)

DCPH

Deciphera

$27.22

-0.45 (-1.63%)

FATE

Fate Therapeutics

$16.69

0.69 (4.31%)

GBT

Global Blood Therapeutics

$51.94

-0.425 (-0.81%)

IMMU

Immunomedics

$16.60

-0.36 (-2.12%)

INCY

Incyte

$84.17

-0.94 (-1.10%)

JAZZ

Jazz Pharmaceuticals

$135.58

-0.29 (-0.21%)

SRPT

Sarepta

$137.03

-11.78 (-7.92%)

STML

Stemline

$11.71

-0.29 (-2.42%)

XLRN

Acceleron

$46.28

-0.16 (-0.34%)

ZGNX

Zogenix

$52.32

-0.33 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 12

    Mar

  • 18

    Mar

  • 20

    Mar

  • 24

    May

  • 19

    Aug

  • 06

    Mar

FATE

Fate Therapeutics

$16.00

-0.22 (-1.36%)

08:59
03/06/19
03/06
08:59
03/06/19
08:59
Recommendations
Fate Therapeutics analyst commentary at Wells Fargo »

Fate Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$25.51

0.78 (3.15%)

, BCRX

BioCryst

$8.33

-0.45 (-5.13%)

05:16
03/06/19
03/06
05:16
03/06/19
05:16
Recommendations
Aimmune, BioCryst, Deciphera, Fate Therapeutics, Global Blood Therapeutics, Immunomedics, Incyte, Jazz Pharmaceuticals, Loxo Oncology, Sarepta, Stemline, Acceleron, Zogenix analyst commentary at Piper Jaffray »

Departure of Gottlieb…

AIMT

Aimmune

$25.51

0.78 (3.15%)

BCRX

BioCryst

$8.33

-0.45 (-5.13%)

DCPH

Deciphera

$27.67

-1 (-3.49%)

FATE

Fate Therapeutics

$16.00

-0.22 (-1.36%)

GBT

Global Blood Therapeutics

$52.36

-0.32 (-0.61%)

IMMU

Immunomedics

$16.96

0.04 (0.24%)

INCY

Incyte

$85.11

-0.29 (-0.34%)

JAZZ

Jazz Pharmaceuticals

$135.87

1.36 (1.01%)

LOXO

Loxo Oncology

$0.00

(0.00%)

SRPT

Sarepta

$148.81

3.37 (2.32%)

STML

Stemline

$12.00

0.57 (4.99%)

XLRN

Acceleron

$46.44

0.19 (0.41%)

ZGNX

Zogenix

$52.65

0.71 (1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 18

    Mar

  • 20

    Mar

  • 24

    May

  • 19

    Aug

  • 06

    Mar

FATE

Fate Therapeutics

$16.12

-0.1 (-0.62%)

16:06
03/05/19
03/05
16:06
03/05/19
16:06
Earnings
Fate Therapeutics reports Q4 EPS (25c), consensus (24c) »

Reports Q4 revenue $1.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

Over a month ago
EXEL

Exelixis

$22.06

0.37 (1.71%)

, SPPI

Spectrum

$11.83

0.21 (1.81%)

07:41
02/14/19
02/14
07:41
02/14/19
07:41
Conference/Events
Guggenheim to hold a conference »

Guggenheim Healthcare…

EXEL

Exelixis

$22.06

0.37 (1.71%)

SPPI

Spectrum

$11.83

0.21 (1.81%)

ALLO

Allogene Therapeutics

$31.96

0.57 (1.82%)

BMY

Bristol-Myers

$50.97

1.24 (2.49%)

FTSV

Forty Seven

$15.33

0.39 (2.61%)

LLY

Eli Lilly

$119.08

0.27 (0.23%)

REPL

Replimune Group

$13.90

-1.37 (-8.97%)

XNCR

Xencor

$35.87

-0.27 (-0.75%)

MRUS

Merus

$11.94

-0.06 (-0.50%)

IOVA

Iovance Biotherapeutics

$9.79

0.12 (1.24%)

FATE

Fate Therapeutics

$14.73

-0.27 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 14

    Feb

  • 18

    Feb

  • 28

    Feb

  • 02

    Apr

  • 18

    May

  • 20

    May

C

Citi

$62.81

-1.1 (-1.72%)

, GSK

GlaxoSmithKline

$40.57

-0.1 (-0.25%)

04:55
02/08/19
02/08
04:55
02/08/19
04:55
Conference/Events
The Conference Forum to hold a conference »

5th Annual…

C

Citi

$62.81

-1.1 (-1.72%)

GSK

GlaxoSmithKline

$40.57

-0.1 (-0.25%)

DNA

Bought by RHHBY

$0.00

(0.00%)

MRK

Merck

$76.82

-0.58 (-0.75%)

MEDI

Medimmune

$0.00

(0.00%)

NKTR

Nektar

$43.82

-0.51 (-1.15%)

IOVA

Iovance Biotherapeutics

$9.69

-0.16 (-1.62%)

NEO

NeoGenomics

$16.31

-0.24 (-1.45%)

FATE

Fate Therapeutics

$13.33

-0.86 (-6.06%)

MDSO

Medidata

$73.55

-1.59 (-2.12%)

NSTG

NanoString

$22.39

-0.09 (-0.40%)

NTGN

Neon Therapeutics

$5.02

-0.03 (-0.59%)

PRAH

PRA Health

$105.75

-2.25 (-2.08%)

BTAI

BioXcel Therapeutics

$8.25

0.4 (5.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 11

    Feb

  • 12

    Feb

  • 14

    Feb

  • 16

    Feb

  • 19

    Feb

  • 25

    Feb

  • 02

    Apr

  • 11

    Apr

  • 18

    May

  • 28

    May

  • 13

    Jul

C

Citi

$63.91

0.13 (0.20%)

, GSK

GlaxoSmithKline

$40.67

1.215 (3.08%)

04:55
02/07/19
02/07
04:55
02/07/19
04:55
Conference/Events
The Conference Forum to hold a conference »

5th Annual…

C

Citi

$63.91

0.13 (0.20%)

GSK

GlaxoSmithKline

$40.67

1.215 (3.08%)

DNA

Bought by RHHBY

$0.00

(0.00%)

MRK

Merck

$77.40

0.26 (0.34%)

MEDI

Medimmune

$0.00

(0.00%)

NKTR

Nektar

$44.33

0.64 (1.46%)

IOVA

Iovance Biotherapeutics

$9.85

0.35 (3.68%)

NEO

NeoGenomics

$16.55

-0.37 (-2.19%)

FATE

Fate Therapeutics

$14.19

0.33 (2.38%)

MDSO

Medidata

$75.14

0.44 (0.59%)

NSTG

NanoString

$22.48

-0.21 (-0.93%)

NTGN

Neon Therapeutics

$5.05

0.84 (19.95%)

PRAH

PRA Health

$108.00

-0.11 (-0.10%)

BTAI

BioXcel Therapeutics

$7.85

1.23 (18.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 11

    Feb

  • 12

    Feb

  • 14

    Feb

  • 16

    Feb

  • 19

    Feb

  • 25

    Feb

  • 02

    Apr

  • 11

    Apr

  • 18

    May

  • 28

    May

  • 13

    Jul

C

Citi

$63.78

-0.28 (-0.44%)

, GSK

GlaxoSmithKline

$39.46

0.305 (0.78%)

08:14
02/06/19
02/06
08:14
02/06/19
08:14
Conference/Events
The Conference Forum to hold a conference »

5th Annual…

C

Citi

$63.78

-0.28 (-0.44%)

GSK

GlaxoSmithKline

$39.46

0.305 (0.78%)

DNA

Bought by RHHBY

$0.00

(0.00%)

MRK

Merck

$77.14

0.28 (0.36%)

MEDI

Medimmune

$0.00

(0.00%)

NKTR

Nektar

$43.69

1.19 (2.80%)

IOVA

Iovance Biotherapeutics

$9.50

-0.53 (-5.28%)

NEO

NeoGenomics

$16.92

0.36 (2.17%)

FATE

Fate Therapeutics

$13.86

-0.18 (-1.28%)

MDSO

Medidata

$74.70

1.21 (1.65%)

NSTG

NanoString

$22.69

0.08 (0.35%)

NTGN

Neon Therapeutics

$4.21

-0.08 (-1.86%)

PRAH

PRA Health

$108.11

-0.26 (-0.24%)

BTAI

BioXcel Therapeutics

$6.62

0.65 (10.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 06

    Feb

  • 11

    Feb

  • 12

    Feb

  • 14

    Feb

  • 16

    Feb

  • 19

    Feb

  • 25

    Feb

  • 02

    Apr

  • 11

    Apr

  • 18

    May

  • 28

    May

  • 13

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.